Ganciclovir description

Revision as of 22:04, 5 January 2014 by ShiSheng (talk | contribs) (Created page with "__NOTOC__ {{Ganciclovir}} {{CMG}} ==Description== The Vitrasert Implant contains the antiviral drug ganciclovir. Each Vitrasert Implant contains a minimum of 4.5 mg ganciclov...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search
Ganciclovir
VITRASERT® FDA Package Insert
Description
Clinical Pharmacology
Microbiology
Indications and Usage
Contraindications
Warnings and Precautions
Adverse Reactions
Drug Interactions
Clinical Studies
Dosage and Administration
How Supplied
Labels and Packages

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Description

The Vitrasert Implant contains the antiviral drug ganciclovir. Each Vitrasert Implant contains a minimum of 4.5 mg ganciclovir.

Each Vitrasert Implant contains a ganciclovir tablet which contains the inactive ingredient, magnesium stearate (0.25%). Each tablet is coated with polyvinyl alcohol and ethylene vinyl acetate polymers.

The chemical name of ganciclovir is 9-[[2-hydroxy -1- (hydroxymethyl)ethoxy] methyl]guanine, and has the following structure:

[1]

References

  1. "http://www.drugbank.ca/system/fda_labels/DB01004.pdf?1265922812" (PDF). External link in |title= (help)

Adapted from the FDA Package Insert.